A Mangiagli

689 total citations
20 papers, 494 citations indexed

About

A Mangiagli is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, A Mangiagli has authored 20 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 8 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in A Mangiagli's work include Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (8 papers) and Pharmacological Effects and Toxicity Studies (4 papers). A Mangiagli is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (8 papers) and Pharmacological Effects and Toxicity Studies (4 papers). A Mangiagli collaborates with scholars based in Italy, Switzerland and Germany. A Mangiagli's co-authors include M A Romeo, G Pizzarelli, F. Di Gregorio, C Melevendi, V. Carnelli, Domenico De Mattia, Salvatore Musumeci, Riccardo Longhi, A. Di Palma and Caterina Borgna Pignatti and has published in prestigious journals such as Blood, Clinical Endocrinology and Journal of Infection.

In The Last Decade

A Mangiagli

20 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Mangiagli Italy 10 390 359 93 56 45 20 494
T. Lombardo Italy 11 278 0.7× 229 0.6× 54 0.6× 101 1.8× 37 0.8× 22 434
Vassilis Ladis Greece 12 384 1.0× 359 1.0× 53 0.6× 31 0.6× 65 1.4× 17 447
Talia İleri Türkiye 12 104 0.3× 184 0.5× 48 0.5× 42 0.8× 11 0.2× 43 353
Sandra Regina Loggetto Brazil 9 191 0.5× 207 0.6× 31 0.3× 26 0.5× 43 1.0× 24 296
Malai Wongchanchailert Thailand 11 167 0.4× 172 0.5× 99 1.1× 15 0.3× 7 0.2× 34 350
Gülsün Karasu Türkiye 12 71 0.2× 148 0.4× 109 1.2× 58 1.0× 8 0.2× 47 403
Chisaki Mizumoto Japan 10 86 0.2× 129 0.4× 11 0.1× 36 0.6× 24 0.5× 33 283
A Marín-López Mexico 9 46 0.1× 211 0.6× 66 0.7× 14 0.3× 9 0.2× 24 322
José E. Navarrete United States 7 174 0.4× 151 0.4× 26 0.3× 12 0.2× 11 0.2× 17 278
Raheel Iftikhar Pakistan 11 47 0.1× 108 0.3× 17 0.2× 54 1.0× 22 0.5× 47 307

Countries citing papers authored by A Mangiagli

Since Specialization
Citations

This map shows the geographic impact of A Mangiagli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Mangiagli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Mangiagli more than expected).

Fields of papers citing papers by A Mangiagli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Mangiagli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Mangiagli. The network helps show where A Mangiagli may publish in the future.

Co-authorship network of co-authors of A Mangiagli

This figure shows the co-authorship network connecting the top 25 collaborators of A Mangiagli. A scholar is included among the top collaborators of A Mangiagli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Mangiagli. A Mangiagli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campisi, Saveria, A Mangiagli, Vitaliana De Sanctis, & M Giovannini. (2011). Paraplegia in a thalassaemic patient with short stature.. PubMed. 8 Suppl 2. 340–4. 3 indexed citations
2.
Sanctis, Vincenzo De, et al.. (2005). Growth hormone secretion in adult patients with thalassaemia. Clinical Endocrinology. 62(6). 667–671. 15 indexed citations
3.
Cappellini, Maria Domenica, Mohamed Béjaoui, Leyla Ağaoğlu, et al.. (2005). Patient Satisfaction with Deferasirox (Exjade®, ICL670) an Oral Form of Chelation Therapy Versus Deferoxamine an Infused Chelation Therapy.. Blood. 106(11). 2704–2704. 12 indexed citations
4.
Angelucci, Emanuele, Bruno Turlin, Duran Canatan, et al.. (2005). Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Is Effective in Reducing Iron Overload in Patients with Advanced Fibrosis and Cirrhosis.. Blood. 106(11). 2696–2696. 6 indexed citations
5.
Mangiagli, A, Saveria Campisi, Vincenzo De Sanctis, et al.. (2004). Effects of acarbose in patients with beta-thalassaemia major and abnormal glucose homeostasis.. PubMed. 2 Suppl 2. 276–8. 9 indexed citations
6.
Mangiagli, A, Saveria Campisi, Vincenzo De Sanctis, et al.. (2004). Effects of acarbose in beta-thalassaemia major patients with normal glucose tolerance and hyperinsulinism.. PubMed. 2 Suppl 2. 272–5. 8 indexed citations
8.
Mangiagli, A, et al.. (2002). Impaired Glucose Homeostasis in Young Adult Thalassemic Patients: A Pilot Study with Acarbose. Journal of Pediatric Endocrinology and Metabolism. 15(2). 205–10. 2 indexed citations
9.
Maggio, Aurelio, Gennaro D’Amico, Alberto Morabito, et al.. (2002). Deferiprone versus Deferoxamine in Patients with Thalassemia Major: A Randomized Clinical Trial. Blood Cells Molecules and Diseases. 28(2). 196–208. 154 indexed citations
10.
Mangiagli, A, et al.. (2000). Treatment with Deferiprone (LI) in a Thalassaemic Patient with Bone Lesions due to Desferrioxamine. Journal of Pediatric Endocrinology and Metabolism. 13(6). 677–80. 5 indexed citations
11.
Volti, S. Li, A. Sciotto, P. Marco Fisichella, et al.. (1999). Immune responses to administration of a vaccine against Haemophilus influenzae Type B in splenectomized and non-splenectomized patients. Journal of Infection. 39(1). 38–41. 6 indexed citations
12.
Caruso‐Nicoletti, Manuela, Vitaliana De Sanctis, Maria Elena Capra, et al.. (1998). Short stature and body proportion in thalassaemia.. PubMed. 11 Suppl 3. 811–6. 19 indexed citations
13.
Mangiagli, A. (1998). [Prevalence of hepatitis A antibodies in polytransfused thalassemic patients].. PubMed. 19(6). 437–8. 1 indexed citations
14.
Pignatti, Caterina Borgna, V. Carnelli, Vincenzo Caruso, et al.. (1998). Thromboembolic Events in Beta Thalassemia Major: An Italian Multicenter Study. Acta Haematologica. 99(2). 76–79. 158 indexed citations
15.
Mangiagli, A, et al.. (1998). Glucose tolerance and beta-cell secretion in patients with thalassaemia major.. PubMed. 11 Suppl 3. 985–6. 7 indexed citations
16.
Giardini, Claudio, M Galimberti, Giuseppe Lucarelli, et al.. (1997). α-Interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous β-thalassemia. Bone Marrow Transplantation. 20(9). 767–772. 28 indexed citations
17.
Mangiagli, A & Saveria Campisi. (1996). [Celiac disease associated with major thalassemia. A case report].. PubMed. 48(9). 401–5. 6 indexed citations
18.
Mangiagli, A, et al.. (1995). [Horizontal transmission of hepatitis C virus to family members of infected polytransfused pediatric patients].. PubMed. 17(2). 151–2. 1 indexed citations
19.
Volti, S. Li, M A Romeo, Lorenzo Lupo, et al.. (1994). Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients.. PubMed. 14(2). 225–7. 21 indexed citations
20.
Romeo, Mario, et al.. (1991). Familial Jarcho‐Levin syndrome. Clinical Genetics. 39(4). 253–259. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026